ZHOU Hong,DUAN Hong,GAO Jian-jun,et al.Clinical Characteristics and Pathogenic Gene Analysis of Children with Noonan Syndrome[J].Chinese Scientific Journal of Hearing and Speech Rehabilitation,2024,22(01):99-102.
ZHOU Hong,DUAN Hong,GAO Jian-jun,et al.Clinical Characteristics and Pathogenic Gene Analysis of Children with Noonan Syndrome[J].Chinese Scientific Journal of Hearing and Speech Rehabilitation,2024,22(01):99-102. DOI: 10.3969/j.issn.1672-4933.2024.01.026.
Clinical Characteristics and Pathogenic Gene Analysis of Children with Noonan Syndrome
Noonan syndrome (NS) is an autosomal dominant disorder characterized by multiple system impairments
such as distinctive facial deformities
congenital heart defects
short stature
cryptorchidism
lymphatic malformations
hemorrhagic disorders
and skeletal malformations.Some patients have hearing difficulties.It has been reported that NS is a rare cause of sensorineural deafness.This study describes a patient with Noonan syndrome with bilateral severe hearing loss who underwent a successful cochlear implantation. In 2019
the child was admitted to the Children's Hospital Affiliated to Capital Medical University with neurological deafness
special facial features and growth and development problems
and was diagnosed as Noonan syndrome type 1 after whole exome sequencing detected the presence of C.417G
>
C pathogenic variation in
PTPN11
gene. In this study
the mutation identification of pathogenic gene
PTPN11
can assist clinical diagnosis
and provide guidance for genetic counseling of family members and future eugenics of patients.
Roberts AE, Allanson JE, Tartaglia M, et al. Noonan syndrome [J]. Lancet, 2013, 381(9863):333-342.
Van der Burgt I, Berends E, Lommen E, et al. Clinical and molecular studies in a large Dutch family with Noonan syndrome[J]. Am J Med Genet, 1994,53(2):187-191.
Fragale A,Tartaglia M,Wu J,et al. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation[J]. Hum Mutat,2004,23(3):267-277.
Zenker M, Edouard T, Blair JC, et al. Noonan syndrome: improving recognition and diagnosis[J]. Arch Dis Child, 2022,107(12):1073-1078.
Tajan M, Paccoud R, Branka S, et al. The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway [J]. Endocr Rev, 2018,39(5):676-700.
Grant AR, Cushman BJ, Cavé H, et al. Assessing the gene- disease association of 19 genes with the RASopathies using the ClinGen gene curation framework [J]. Hum Mutat, 2018, 39(11):1485-1493.
Capri Y, Flex E, Krumbach OHF, et al. Activating mutations of RRAS2 are a rare cause of Noonan syndrome [J]. Am J Hum Genet, 2019,104(6):1223-1232.
Pandit B, Sarkozy A, Pennacchio LA, et al. Gain- Of- Function Raf1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy [J]. Nat Genet, 2007, 39(8):1007-1012.
Kouz K, Lissewski C, Spranger S, et al. Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation [J]. Genet Med, 2016, 18(12):1226-1234.
Strullu M, Caye A, Lachenaud J, et al. Juvenile myelomonocytic leukaemia and Noonan syndrome [J]. J Med Genet, 2014,51(10):689-697.
Croll PH,Vinke EJ,Armstrong NM,et al. Hearing loss and cognitive decline in the general population: a prospective cohort study [J]. J Neurol, 2021, 268(3):860-871.
Sharland M, Burch M, McKenna WM, et al. A clinical study of Noonan syndrome [J]. Arch Dis Child, 1992 ,67(2):178-183.
van Trier DC, van Nierop J, Draaisma JMT,et al. External ear anomalies and hearing impairment in Noonan Syndrome [J]. Int J Pediatr Otorhinolaryngol, 2015,79(6):874-878.